Summer Updates from CellEDIT🌞
Greetings,
We are excited to bring you the latest from CellEDIT. This July issue is packed with exciting updates, including our recent peer-reviewed publication, insights from our expert team, and a special summer sale! Happy Reading!
📝 CellEDIT Publication in the Peer-Reviewed Biotechnology Journal
The recent article, “Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9,” showcases CellEDIT's innovative approach to cell engineering.
Key Findings:
✅ CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells.
✅ Control of the amount and stoichiometry of RNP complexes could boost efficiency, particularly when targeting multiple loci simultaneously.
✅ Demonstrated preservation of general cell characteristics and functionality post-editing in both single and multiple KO clones in CHO-K1 cells.
You can find the press release summarizing the findings and the link to the open-access publication here.
Inspired? Take advantage of our summer sale to customize your CHO Cell Line (scroll down for more details 👇).
🕵🏻 Meet the Team Behind CellEDIT! 🧬
Our CellEDIT team explains how FluidFM® technology enables precise, high-quality gene-edited mammalian cell lines tailored to researchers' needs in the Scientist.com piece "Behind CellEDIT Service: The Experts Crafting Top-Quality Genetically Engineered Cell Lines for Researchers Worldwide". Enjoy!
Highlights:
⭐Customer Focus: Customizable solutions for specific research requirements.
⭐Versatility: Handles complex edits and difficult-to-transfect cells.
⭐Lab Automation: Advanced automation systems for efficient and precise cell engineering.
⭐R&D: Continuous research and development to expand offerings and enhance capabilities.
⭐And More…
Featuring: Dr. Susanne Mailand, Dr. Adele Kerjouan, Uwe Heuzeroth, Dr. Xuan Droz, Dr. Gorka Santos Fernández, and Dr. Tobias Beyer.
🔍 Your Cells & Edits. Our Expertise.
Browse our custom cell lines: from hard-to-transfect to breast cancer cells… We’ll handle the CRISPR editing of your cell line with a 10-week delivery time while you enjoy the summer ⛱️ 🍉🌊☀️🕶.
💬 Join the Community!
Follow us on X, LinkedIn, and Facebook to stay updated with the latest news and events, and subscribe to our CellEDIT Newsletter. The next newsletter is in September.
📨 Stay in Touch!
If you have any questions, feel free to contact us at marketing@cytosurge.com. We're here to help!
Best Regards,
Erica @Cytosurge